Difficulty: Medium
Average Score: 72%
Practice
A 42-year-old woman with a 1-year history of rheumatoid arthritis comes to see her primary care physician complaining of worsening symptoms. She has been taking leflunomide. IL-1 and TNF-α are two key cytokines involved in the negative sequelae of rheumatoid arthritis. Which of the following drugs is a recombinant form of an endogenous IL-1 antagonist?
Correct answer
B
Rationale
RA involves IL-1 and TNF-α driving inflammation. The question seeks a recombinant IL-1 antagonist. Abatacept inhibits T-cell costimulation, not IL-1. Anakinra , a recombinant IL-1 receptor antagonist (IL-1Ra), blocks IL-1 signaling, matching the description. Methotrexate slows cell proliferation, not an IL-1 antagonist. Hydroxychloroquine modulates immunity differently. Rituximab (E) targets B cells. Anakinra mimics natural IL-1Ra, reducing joint damage in RA when leflunomide fails, directly countering IL-1's effects, unlike broader or unrelated mechanisms of other options.